IP Verse

Single Dose Anti-Pcv2 Pig Vaccine

Patent No. EP2481420 (titled "Single Dose Anti-Pcv2 Pig Vaccine") was filed by Boehringer Ingelheim on Dec 14, 2007. The application was issued on Feb 20, 2019.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
LABORATORIOS HIPRANov 20, 2019GRUNECKER PATENT
CEVA SANTE ANIMALENov 19, 2019CABINET BECKER ET ASSOCIES

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2481420

BOEHRINGER INGELHEIM
Application Number
EP12155194A
Filing Date
Dec 14, 2007
Status
Granted And Under Opposition
Jan 18, 2019
Publication Date
Feb 20, 2019
External Links
Slate, Register , Google Patents